With ever changing policies, new initiatives, and increased demand for public access to clinical trial data and documents, managing both voluntary and legal requirements for data sharing can be challenging for even the most established organisations. Careful planning is critical in data sharing, in order to balance anonymisation and patient privacy with the inclusion of relevant information. Additionally, sponsors must be prepared to navigate policy changes and different expectations between regulatory agencies.

Read the whitepaper to discover:

• Key data sharing drivers
• An overview of the current regulatory landscape
• Strategies for protecting patient privacy
• Recommendations for establishing internal teams to support data sharing